Jorge Augusto Diaz Rojas
Overview
Explore the profile of Jorge Augusto Diaz Rojas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parra Gonzalez D, Perez Mesa J, Cuervo Maldonado S, Diaz Rojas J, Cortes J, Silva Gomez E, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358178
Previous research has determined that the required doses for treating febrile neutropenia with vancomycin are higher than the doses used conventionally. These recommendations have been made considering pharmacotherapeutic goals based...
2.
Augustovski F, Diaz Rojas J, Ferraz M, Hernandez I, Korenblat Donato B, Raimundo K, et al.
Value Health Reg Issues
. 2018 Apr;
1(2):223-227.
PMID: 29702904
In Latin America, social security and public sectors represent the largest financiers and providers of health care. Many countries in the region have compulsory packages of basic health care benefits....
3.
Munoz-Galindo I, Moreno Calderon J, Guarin Tellez N, Arevalo Roa H, Diaz Rojas J
Value Health Reg Issues
. 2018 Apr;
17:14-20.
PMID: 29605798
Background: There have been many studies on the cost of multiple sclerosis in countries with high prevalence, whereas in Latin America such analyses are few. Taking into consideration the burden...
4.
Casadiego Rincon E, Diaz Rojas J, Bermudez C, Martinez V
Value Health Reg Issues
. 2016 Dec;
11:9-16.
PMID: 27986205
Objective: To assess the cost-effectiveness of prophylactic administration of Granulocyte Colony-Stimulating Factor (G-CSF) compared with no use of it, during the induction phase of chemotherapy in Adults with Acute Lymphoblastic...
5.
Guarin Tellez N, Moreno Calderon J, Munoz-Galindo I, Diaz Rojas J, Arevalo Roa H
Value Health Reg Issues
. 2016 Dec;
11:1-8.
PMID: 27986193
Background: In Colombia, HIV and AIDS constitute one of the major diseases of high cost to the health system, making necessary health risk management of patients with this disease through...